Skip to content
Biodatica
Start free

Beijing Geekgene Technology Co., LTD

Beijing

OncologyPhase II
Compare Sign in to watch

What changed

Phase I trial registered: A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer

2w agoTrial registeredJun 29, 2026Source filing (opens the source filing in a new tab)

Momentum

80no change

Momentum 80 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,206 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    EARLY_PHASE1 registered

    Jul 1, 2026

    Advanced Lung Cancer · NOT_YET_RECRUITING · sponsor: Beijing Geekgene Technology Co., LTD · A Clinical Study GK01 Cell Injection in Subjects With Advanced Lung Cancer

    ClinicalTrials.gov · NCT07673419 (opens the source filing in a new tab)

  2. Trial

    PHASE1 registered

    Apr 1, 2026

    Advanced Solid Tumors · NOT_YET_RECRUITING · sponsor: Beijing Geekgene Technology Co., LTD · A Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid Tumors

    ClinicalTrials.gov · NCT07482319 (opens the source filing in a new tab)

  3. Trial

    PHASE2 registered

    Jan 31, 2026

    Small Cell Lung Carcinoma · NOT_YET_RECRUITING · sponsor: Peking University Cancer Hospital & Institute · Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD

    ClinicalTrials.gov · NCT07357532 (opens the source filing in a new tab)

  4. Trial

    Study registered

    Jan 1, 2025

    Gastric Cancer, Immunotherapy · RECRUITING · sponsor: Changzhi People's Hospital Affiliated to Changzhi Medical College · The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment

    ClinicalTrials.gov · NCT07069842 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources